asa glp 1 Are Serious Anesthesia Risks of Semaglutide and Other GLP-1 Agonists Under-Recognized? Case Reports of Retained Solid Gastric Contents in Patients Undergoing Anesthesia ASA Advises No Longer Holding

Carnitine also improved oxidative and inflammatory markers in patients with cardiovascular disease (62) , but did not have any impact on blood pressure (66) or reduce risk of death or heart failure in patients with anterior acute myocardial infarction (36)

Peter Attia, a longevity physician, discusses NAD+ precursors: "While evidence is emerging, NAD+ boosting shows promise for mitochondrial health and longevity, though IV might not be optimalprecursors like NMN could be better."[33][20] On combinations, he cautions on long-term data but notes potential for metabolic disorders

Appetite suppression may lift, meaning your hunger could increase, and portion sizes or cravings might change

closer ophthalmic monitoring is advisable in this group, consistent with NICE guidance on type 2 diabetes management Individuals with renal impairment or those prone to volume depletion : Significant gastrointestinal losses increase the risk of AKI

0.16 mg

No published human study tracks continuous use beyond 12 weeks, making extended unsupervised administration an undocumented risk with the current state of evidence on BPC-157